Liam from Norway

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Johnson & Johnson (JNJ) stock information

Johnson & Johnson

24h Change

0.13 %

JNJ

Live rate: Market closed

Stock data per Tuesday 26 May, 2020

JNJ
New York Stock Exchange
144.37
146.19
144.56
0.19 (+ 0.13%)
US Market is closed

Live Stock price in graph for Johnson & Johnson (JNJ)

Data updated continously for JNJ, showing up to the 500 most recent 100 data points

  • Latest Volume

    7,071,199 (15.15 %)

  • Volume prev. day

    6,140,899

  • Avg. daily volume

    8,605,342

  • Market cap

    380,856,330,400

  • P/E ratio

    22.23

  • Today high

    146.44

  • Today low

    144.3

  • 52 week high

    157

  • 52 week low

    109.16

  • YTD Change

    n/a

 

Latest news about Johnson & Johnson

Below you can find the most recent news posts about Johnson & Johnson, primarily from US and UK based news sources.

The Zacks Analyst Blog Highlights: Bristol-Myers, Roche, AstraZeneca, Merck and Johnson & Johnson

Tuesday, 26 May 2020, 14:53:00
The Zacks Analyst Blog Highlights: Bristol-Myers, Roche, AstraZeneca, Merck and Johnson & Johnson
— Zacks Investment Research


Major pharma companies rejected a 2017 EU proposal that could let vaccines for viruses like the coronavirus be developed before an outbreak

Monday, 25 May 2020, 10:21:00
A 2017 proposal that would speed up vaccine production in the EU was blocked by major pharmaceutical companies, The Guardian reported . The proposal would fund improvements to testing, potentially allowing approval to be fast-tracked and for vaccines against viruses like the novel coronavirus to be developed before an outbreak begins. But it was rejected by the pharmaceutical companies on the IMI, a body dedicated to improving the EU’s pharmaceutical research. Representatives of a group that includes GlaxoSmithKline, Novartis, Pfizer, and Johnson & Johnson are part of that body, The Guardian reported . The IMI rejected the claim that it has focused on other illnesses to the detriment of the coronavirus, pointing to investments it has made in vaccines and in light of the Ebola outbreak. Companies are now rushing to try and create an effective vaccine to tackle the pandemic. Visit Business Insider’s homepage for more stories . The world’s biggest pharmaceutical companies blocked a 2017 EU proposal that could allow vaccines against viruses like the novel coronavirus to be developed before an outbreak begins, The Guardian reported .
— Business Insider


Today’s Pickup: Gartner releases annual Supply Chain Top 25

Friday, 22 May 2020, 19:05:39
Good day, Gartner, Inc. released the results from its annual Supply Chain Top 25 , identifying supply chain leaders and highlighting their best practices. Cisco Systems scored the top spot in the ranking, followed by Colgate-Palmolive, Johnson & Johnson, Schneider Electric, and Nestlé. Six new companies joined this year’s list – Lenovo, AbbVie, British American Tobacco, Reckitt Benckiser, Biogen, and Kimberly-Clark. Three key trends stand out this year for the companies that made the list, Gartner said in a press release. They use a “language of purpose,” recognize that problem solving requires partnership with others in the community and were early and frequent adopters of digital technologies. Did you know? Gross margins for truckload activity managed by 3PLs declined 210 basis points in the first quarter of 2020 compared to a year ago. Intermodal … Full story available on Benzinga.com
— Benzinga Feeds


North American Market for Baby & Adult Diapers Worth $15 Billion by 2025 – Key Players are Kimberly Clark, Procter & Gamble, SCA Hygiene and Johnson & Johnson

Friday, 22 May 2020, 11:16:00
DUBLIN, May 22, 2020 /PRNewswire/ — The “North America Baby & Adult Diaper Market Outlook, 2025” report has been added to ResearchAndMarkets.com’s offering. The North American diaper market is estimated to reach US$14.99 billion in the year 2025 with a growth of more than 2% (CAGR). This…
— PR Newswire


Pharma Stock Roundup: FDA Ok’s Cancer Drugs for New Use, JNJ Stops US Baby Powder Sales

Friday, 22 May 2020, 09:37:09
FDA approves line extensions for Bristol-Myers (BMY), Roche (RHHBY) and AstraZeneca (AZN)/Merck’s (MRK) drugs. J&J stops sales of talc-based baby powders in the United States and Canada.
— Yahoo Finance